DHR:NYSE
Danaher Corp
$227.97
arrow_downward
-1.90%(-4.41) 1D
$227.97
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:03:09 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHR...
Open
$234.20
High
$234.29
Low
$227.53
Mkt. cap
160.38B
Avg. vol.
4.56M
Volume
3.16M
Dividend
0.70%
Quarterly dividend
$0.40
Ex-dividend date
Sep 30, 2026
P/E ratio
37.32
52-wk high
$242.80
52-wk low
$160.93
EPS
$6.11
Beta
0.77
Shares outstanding
703.53M
No. of employees
59K
Open
$234.20
High
$234.29
Low
$227.53
Mkt. cap
160.38B
Avg. vol.
4.56M
Volume
3.16M
Dividend
0.70%
Quarterly dividend
$0.40
Ex-dividend date
Sep 30, 2026
P/E ratio
37.32
52-wk high
$242.80
52-wk low
$160.93
EPS
$6.11
Beta
0.77
Shares outstanding
703.53M
No. of employees
59K
News stories
From web sources and news partners
MarketWatch
·
3 days ago
Danaher Corp. stock underperforms Friday when compared to competitors
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp